25 Lessons Learned from Conducting Robust Risk Assessments in Pharmaceutical Environments (GMP, GCP, GVP, GLP)
Risk assessments play a critical role across pharmaceutical environments, influencing how organisations identify vulnerabilities, implement appropriate controls and maintain inspection readiness. Whether assessing manufacturing processes, clinical activities, pharmacovigilance systems or computerised systems, the quality of a risk assessment can have a significant impact on both compliance and operational oversight. Drawing on practical experience across GMP, [...]